Curetis AG, a German diagnostics company, has raised €18.5 million in a Series A round in order to complete development of its diagnostic products for detecting severe infectious diseases. The round was led by Life Sciences Partners. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals
